Skórzewska Magdalena, Mielko Jerzy, Kurylcio Andrzej, Romanek Jarosław, Polkowski Wojciech P
Department of Surgical Oncology of the Medical University of Lublin, Lublin, Poland.
Contemp Oncol (Pozn). 2016;20(1):52-7. doi: 10.5114/wo.2016.58500. Epub 2016 Mar 16.
Intraoperative radiotherapy (IORT) may improve outcome of surgical treatment of recurrent colorectal cancer (CRC). The aim of this study is to determine the feasibility, safety and long-term results of surgical treatment of recurrent CRC with orthovolt IORT.
Fifty-nine consecutive CRC patients with local recurrence (LR), undergoing surgery, were included in the retrospective analysis of prospectively collected data. The modified Wanebo classification was used to stage LR (Tr). Twenty-five (43%) patients received IORT using INTRABEAM(®) PRS 500. The complications were classified according to the Clavien-Dindo classification.
There were 32 males and 27 females, with a median age of 63 years. Multi-visceral resections were performed in 37 (63%) patients. Median hospitalization time after surgery with IORT was 7 days. One (1.7%) in-hospital postoperative death was reported. Grade 3/4 postoperative complications were found in 11 (19%) patients. Intraoperative radiotherapy had no effect on the postoperative hospitalization time, morbidity and mortality. Median survival after R0 resection was 32 months. Complete resection (R0), no synchronous liver metastases (M0), and no lateral and posterior pelvic wall involvement, were significant predictors of improved survival. Stage of LR was found to be an independent prognostic factor in the multivariate analysis (p = 0.03); Cox regression model). In patients with LR stage < Tr5, a 3-year overall survival (OS) rate was 52%.
Combination of surgical resection and orthovolt IORT is a safe and feasible procedure that does not increase the risk of postoperative complications or prolongs the hospital stay. Despite aggressive surgery supported by IORT, the advanced stage of LR is a limiting factor of long-term survival.
术中放疗(IORT)可能改善复发性结直肠癌(CRC)手术治疗的效果。本研究旨在确定采用常规电压IORT治疗复发性CRC手术的可行性、安全性和长期结果。
对59例接受手术治疗的局部复发性CRC患者进行回顾性分析,这些数据是前瞻性收集的。采用改良的Wanebo分类法对局部复发(Tr)进行分期。25例(43%)患者使用INTRABEAM(®) PRS 500接受IORT。根据Clavien-Dindo分类法对并发症进行分类。
男性32例,女性27例,中位年龄63岁。37例(63%)患者进行了多脏器切除。接受IORT手术后的中位住院时间为7天。报告1例(1.7%)术后住院死亡。11例(19%)患者出现3/4级术后并发症。术中放疗对术后住院时间、发病率和死亡率无影响。R0切除后的中位生存期为32个月。完整切除(R0)、无同步肝转移(M0)以及无侧方和后方盆腔壁受累是生存改善的显著预测因素。在多变量分析中,局部复发分期是一个独立的预后因素(p = 0.03;Cox回归模型)。在局部复发分期<Tr5的患者中,3年总生存率(OS)为52%。
手术切除与常规电压IORT相结合是一种安全可行的手术,不会增加术后并发症风险或延长住院时间。尽管IORT支持下进行了积极的手术,但局部复发的晚期阶段是长期生存的限制因素。